Glial fibrillary acidic protein in cerebrospinal fluid in humans is sensitive to various pre-analytical conditions: possible explanation and solution
Although glial fibrillary acidic protein (GFAP) has potential as a biomarker in cerebrospinal fluid, it is rarely used in clinical diagnosis due to high variability, low reliability, and poor reproducibility of results. Cerebrospinal fluid (CSF) was collected from patients (n = 167) at two sites at...
Saved in:
| Main Authors: | Björn Evertsson, Ingela Nilsson Remahl, Max Albert Hietala, Anja Finn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1627405/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of cerebrospinal fluid tumor-derived DNA to obviate biopsy of IDH-mutant brainstem glioma in an adult
by: Michael Youssef, et al.
Published: (2025-09-01) -
Early cerebrospinal fluid elevations of pTau-217 in severe traumatic brain injury subjects
by: Hamad Yadikar, et al.
Published: (2025-07-01) -
Demonstrating the clinical utility of genomic profiling using cerebrospinal fluid to inform management of central nervous system tumors – a meta analysis of the literature
by: Sakshi Khurana, et al.
Published: (2025-09-01) -
Social anxiety disorder and antibodies against glial cells in the cerebrospinal fluid
by: Judith Weiser, et al.
Published: (2025-10-01) -
Effect of involuntary and voluntary exercise in an enrichment environment on astrogliosis reaction of hippocampus white matter in type 3 diabetic rat models
by: Masoud Jamshidi, et al.
Published: (2022-08-01)